BIOMAT Database Logo BIOMAT Database Logo

Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate. 1996

A Schmidt, and S J Rutledge, and N Endo, and E E Opas, and H Tanaka, and G Wesolowski, and C T Leu, and Z Huang, and C Ramachandaran, and S B Rodan, and G A Rodan
Department of Bone Biology and Osteoporosis Research, Merck Research Laboratories, West Point, PA 19486, USA.

Alendronate (ALN), an aminobisphosphonate used in the treatment of osteoporosis, is a potent inhibitor of bone resorption. Its molecular target is still unknown. This study examines the effects of ALN on the activity of osteoclast protein-tyrosine phosphatase (PTP; protein-tyrosine-phosphate phosphohydrolase, EC 3.1.3.48), called PTPepsilon. Using osteoclast-like cells generated by coculturing mouse bone marrow cells with mouse calvaria osteoblasts, we found by molecular cloning and RNA blot hybridization that PTPepsilon is highly expressed in osteoclastic cells. A purified fusion protein of PTPepsilon expressed in bacteria was inhibited by ALN with an IC50 of 2 microM. Other PTP inhibitors--orthovanadate and phenylarsine oxide (PAO)-inhibited PTPepsilon with IC50 values of 0.3 microM and 18 microM, respectively. ALN and another bisphosphonate, etidronate, also inhibited the activities of other bacterially expressed PTPs such as PTPsigma and CD45 (also called leukocyte common antigen). The PTP inhibitors ALN, orthovanadate, and PAO suppressed in vitro formation of multinucleated osteoclasts from osteoclast precursors and in vitro bone resorption by isolated rat osteoclasts (pit formation) with estimated IC50 values of 10 microM, 3 microM, and 0.05 microM, respectively. These findings suggest that tyrosine phosphatase activity plays an important role in osteoclast formation and function and is a putative molecular target of bisphosphonate action.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D001862 Bone Resorption Bone loss due to osteoclastic activity. Bone Loss, Osteoclastic,Osteoclastic Bone Loss,Bone Losses, Osteoclastic,Bone Resorptions,Loss, Osteoclastic Bone,Losses, Osteoclastic Bone,Osteoclastic Bone Losses,Resorption, Bone,Resorptions, Bone
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004164 Diphosphonates Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents. Bisphosphonate,Bisphosphonates
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme

Related Publications

A Schmidt, and S J Rutledge, and N Endo, and E E Opas, and H Tanaka, and G Wesolowski, and C T Leu, and Z Huang, and C Ramachandaran, and S B Rodan, and G A Rodan
Vascular Endothelial Protein Tyrosine Phosphatase Regulates Endothelial Function.
March 2021, Physiology (Bethesda, Md.),
A Schmidt, and S J Rutledge, and N Endo, and E E Opas, and H Tanaka, and G Wesolowski, and C T Leu, and Z Huang, and C Ramachandaran, and S B Rodan, and G A Rodan
Inhibition of protein phosphatase 2A activity by PI3Kγ regulates β-adrenergic receptor function.
March 2011, Molecular cell,
A Schmidt, and S J Rutledge, and N Endo, and E E Opas, and H Tanaka, and G Wesolowski, and C T Leu, and Z Huang, and C Ramachandaran, and S B Rodan, and G A Rodan
A transmembrane osteoclastic protein-tyrosine phosphatase regulates osteoclast activity in part by promoting osteoclast survival through c-Src-dependent activation of NFkappaB and JNK2.
July 2007, Archives of biochemistry and biophysics,
A Schmidt, and S J Rutledge, and N Endo, and E E Opas, and H Tanaka, and G Wesolowski, and C T Leu, and Z Huang, and C Ramachandaran, and S B Rodan, and G A Rodan
Inhibition of osteoclast function by adenovirus expressing antisense protein-tyrosine kinase 2.
March 2001, The Journal of biological chemistry,
A Schmidt, and S J Rutledge, and N Endo, and E E Opas, and H Tanaka, and G Wesolowski, and C T Leu, and Z Huang, and C Ramachandaran, and S B Rodan, and G A Rodan
A TRPC1 protein-dependent pathway regulates osteoclast formation and function.
August 2013, The Journal of biological chemistry,
A Schmidt, and S J Rutledge, and N Endo, and E E Opas, and H Tanaka, and G Wesolowski, and C T Leu, and Z Huang, and C Ramachandaran, and S B Rodan, and G A Rodan
Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density.
July 1999, The American journal of pathology,
A Schmidt, and S J Rutledge, and N Endo, and E E Opas, and H Tanaka, and G Wesolowski, and C T Leu, and Z Huang, and C Ramachandaran, and S B Rodan, and G A Rodan
Protein tyrosine phosphatase inhibition down-regulates ligand-induced ABCA1 expression.
June 2013, Atherosclerosis,
A Schmidt, and S J Rutledge, and N Endo, and E E Opas, and H Tanaka, and G Wesolowski, and C T Leu, and Z Huang, and C Ramachandaran, and S B Rodan, and G A Rodan
Effects of alendronate on osteoclast formation and activity in vitro.
January 2015, Journal of endodontics,
A Schmidt, and S J Rutledge, and N Endo, and E E Opas, and H Tanaka, and G Wesolowski, and C T Leu, and Z Huang, and C Ramachandaran, and S B Rodan, and G A Rodan
Human osteoclast formation and activity in vitro: effects of alendronate.
November 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
A Schmidt, and S J Rutledge, and N Endo, and E E Opas, and H Tanaka, and G Wesolowski, and C T Leu, and Z Huang, and C Ramachandaran, and S B Rodan, and G A Rodan
The protein tyrosine phosphatase Shp-2 regulates RhoA activity.
November 2000, Current biology : CB,
Copied contents to your clipboard!